University of Texas/Texas AM Investment Management Co (UTIMCO)’s United Therapeutics UTHR Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.05M	Buy	9,328 +5,697	+157%	+$3.21M	0.59%	35
2026 Q1	$2.15M	Buy	3,631 +1,536	+73%	+$765K	0.31%	66
2025 Q4	$1.02M	Buy	+2,095	New	+$976K	0.14%	90
2018 Q4	–	Sell	-315	Closed	-$40K	–	64
2018 Q3	$40K	Buy	+315	New	+$39K	0.05%	15

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s UTHR Position: Q2 2026 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) increased its United Therapeutics (UTHR) stake by 157% in Q2 2026, buying an estimated $3.21M and bringing the position to 9,328 shares worth $5.05M. The position accounts for 0.59% of the portfolio, ranked #35.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in UTHR in Q3 2018 and has held it in 4 quarters since. 560 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

University of Texas/Texas AM Investment Management Co (UTIMCO) held 9,328 shares of United Therapeutics worth $5.05M as of Q2 2026.
University of Texas/Texas AM Investment Management Co (UTIMCO) bought 5,697 United Therapeutics shares in Q2 2026, an estimated $3.21M.
United Therapeutics made up 0.59% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #35 holding.
University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in United Therapeutics in Q3 2018 and has held it in 4 quarters since.
560 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.